PATENT CLAIM ANALYSIS

Application Number: 16181088
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "136100"]

Abstract:
The present invention is in the fields of biochemistry, molecular biology, and Alzheimer's disease diagnosis, prevention, and treatment. Provided herein are humanized antibodies against human tau that are capable of discriminating between normal (healthy) and pathological (disease-associated) tau.

Claim (Index 185):
The composition of  claim 180 , wherein the sequence of the heavy chain variable region comprises SEQ ID NO. 16 and the sequence of the light chain variable region comprises SEQ ID NO. 26.

Metadata:
- Claim Count in Document: 79.0
- Percentile: 98.0
- Lexical Diversity: 1.28947
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15528333', '15342629', '15599685', '15906773', '15207836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7727710364646116
- 35 USC 102 Novelty (BERT): 0.6330876830725762
- Combined Prediction Score: 0.7588027011254082
- Mean Citation Score: 506.236552
- Max Citation Score: 786.5726
- Similarity Product: 520.2432123219252

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test